Earlier this week, we published an article on Mydecine Innovations Group ($MYCO) and their recent changes, developments, and pivots. Following that publication, our very own Charley Rose sat down with the CEO of Mydecine, Josh Bartch. During the interview, Charley does a deep dive into the company and its current positioning in the market. For…